Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers

Y Wang, DP Liu, PP Chen, HP Koeffler, XJ Tong, D Xie - Cancer research, 2007 - AACR
Abstract IFN regulatory factor (IRF)-1 and IRF-2 are generally regarded as a tumor
suppressor and an oncoprotein, respectively. However, little is known about their expression …

[HTML][HTML] HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8–NF-κB axis

W Feng, T Xue, S Huang, Q Shi, C Tang, G Cui… - Cellular & molecular …, 2018 - Springer
Background Hypoxia plays a critical role in many cancers. Hypoxia inducible factor-1α (HIF-
1α) is an important mediator of the hypoxia response. It regulates the expression of various …

IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo

M Yao, L Wang, J Yang, X Yan, Y Cai, D Yao - Tumor Biology, 2016 - Springer
Abnormal expression of insulin-like growth factor I receptor (IGF-IR) is associated with
hepatocellular carcinoma (HCC) progression with largely unknown mechanisms. In this …

High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma

S Aishima, Y Basaki, Y Oda, Y Kuroda… - Cancer …, 2006 - Wiley Online Library
Insulin‐like growth factor binding protein‐3 (IGFBP‐3) modulates cell proliferation of various
cancer cell types. However, it remains unclear how IGF–IGFBP‐3‐signaling is involved in …

Negative feedback regulation of IFN-γ pathway by IFN regulatory factor 2 in esophageal cancers

Y Wang, D Liu, P Chen, HP Koeffler, X Tong, D Xie - Cancer research, 2008 - AACR
IFN-γ is an antitumor cytokine that inhibits cell proliferation and induces apoptosis after
engagement with the IFN-γ receptors (IFNGR) expressed on target cells, whereas IFN …

[HTML][HTML] Downregulation of HIF-1α inhibits the proliferation and invasion of non-small cell lung cancer NCI-H157 cells

J Qian, H Bai, Z Gao, YU Dong, J Pei… - Oncology …, 2016 - spandidos-publications.com
Lung cancer, specifically non-small cell lung cancer (NSCLC), is the leading cause of
cancer‑associated mortality in the world. In previous years, almost no significant …

[HTML][HTML] Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway

Y Qian, Z Du, Y Xing, T Zhou… - Molecular medicine …, 2017 - spandidos-publications.com
The transcription factor, interferon regulatory factor 4 (IRF4), serves an essential role in the
regulation of immune responses, and has been reported to act as a diagnostic and …

The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer

T Sakai, H Mashima, Y Yamada, T Goto, W Sato… - Pancreas, 2014 - journals.lww.com
Objective Pancreatic cancer is one of the most malignant diseases worldwide. Interferon
regulatory factor (IRF) 1 and IRF2 function as a tumor suppressor and oncoprotein …

Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti–programmed cell death …

H Wu, Y Li, G Shi, S Du, X Wang, W Ye, Z Zhang… - …, 2022 - Wiley Online Library
Abstract Background and Aims Therapeutic blockade of the programmed cell death protein‐
1 (PD‐1) immune checkpoint pathways has resulted in significant reactivation of T cell …

Expression and clinical significance of ILF2 in gastric cancer

Z Yin, X Jiang, W Shi, Q Gui, D Yu - Disease markers, 2017 - Wiley Online Library
The aim of this study is to investigate the expression levels and clinical significance of ILF2
in gastric cancer. The mRNA and protein expression levels of ILF2 were, respectively …